Abstract
Acute coronary syndromes (ACS), i.e. unstable angina and myocardial infarction, are the leading causes of death in developed countries and developing countries alike. Lipid lowering intervention studies have demonstrated a 30% risk reduction in recurrent cardiovascular events and death, despite only modest improvement in angiographic stenosis. This discrepancy suggested that cholesterol lowering by statins may lead to stabilization of vulnerable plaques rather than reducing stenosis per se. The predominant effect of statins is to lower lipid levels by inhibiting cholesterol biosynthesis. Besides the lipid lowering effects, statins have also been shown to modulate the inflammatory status and improve endothelial function amongst others, commonly referred to as “pleiotropic effects”. In the present review we will discuss different determinants which lead to plaque vulnerability and subsequently we will expand on the plaque stabilizing or “pleiotropic” effects of statin treatment.
Keywords: Plaque vulnerability, pleiotropic, statins, HMG-CoA reductase inhibitors
Current Pharmaceutical Design
Title: Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?
Volume: 13 Issue: 10
Author(s): Fatima Akdim, Sander I. van Leuven, John J. P. Kastelein and Erik S. G. Stroes
Affiliation:
Keywords: Plaque vulnerability, pleiotropic, statins, HMG-CoA reductase inhibitors
Abstract: Acute coronary syndromes (ACS), i.e. unstable angina and myocardial infarction, are the leading causes of death in developed countries and developing countries alike. Lipid lowering intervention studies have demonstrated a 30% risk reduction in recurrent cardiovascular events and death, despite only modest improvement in angiographic stenosis. This discrepancy suggested that cholesterol lowering by statins may lead to stabilization of vulnerable plaques rather than reducing stenosis per se. The predominant effect of statins is to lower lipid levels by inhibiting cholesterol biosynthesis. Besides the lipid lowering effects, statins have also been shown to modulate the inflammatory status and improve endothelial function amongst others, commonly referred to as “pleiotropic effects”. In the present review we will discuss different determinants which lead to plaque vulnerability and subsequently we will expand on the plaque stabilizing or “pleiotropic” effects of statin treatment.
Export Options
About this article
Cite this article as:
Akdim Fatima, van Leuven I. Sander, P. Kastelein J. John and G. Stroes S. Erik, Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?, Current Pharmaceutical Design 2007; 13 (10) . https://dx.doi.org/10.2174/138161207780487548
DOI https://dx.doi.org/10.2174/138161207780487548 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia
Current Psychiatry Reviews Intrauterine Intervention for the Treatment of Fetal Growth Restriction
Current Pediatric Reviews Adiponectin as a Target in Obesity-related Inflammatory State
Endocrine, Metabolic & Immune Disorders - Drug Targets Imaging Reporters and Multimodal Molecular Bio-Imaging: A Database of Available Probes for Multi-Modality Bio-Imaging of Reporter Gene Expression
Recent Patents on Medical Imaging Orthotopic Heart Transplantation in Patients with Univentricular Physiology
Current Cardiology Reviews The role of interleukin 35 in atherosclerosis
Current Pharmaceutical Design Treatment for Obsessive Compulsive Disorder
Current Psychiatry Reviews Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets Fullerenes for Cancer Diagnosis and Therapy: Preparation, Biological and Clinical Perspectives
Current Drug Metabolism Recent Applications of Peanut Phytoalexins
Recent Patents on Food, Nutrition & Agriculture Emerging Therapies for Type 2 Diabetes
Current Drug Therapy Intrinsically Fluorescent Base-Discriminating Nucleoside Analogs
Mini-Reviews in Organic Chemistry An Apple Plus a Brazil Nut a Day Keeps the Doctors Away: Antioxidant Capacity of Foods and their Health Benefits
Current Pharmaceutical Design Bacterial Urease and its Role in Long-Lasting Human Diseases
Current Protein & Peptide Science Synthesis and Biological Evaluation of Ezetimibe Analogs as Possible Cholesterol Absorption Inhibitors
Letters in Drug Design & Discovery Biomarkers of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), A Review of Published Patents and Patent Applications
Recent Patents on Biomarkers Oxidative Stress as a Regulator of Murine Atherosclerosis
Current Drug Targets Mechanisms of Inflammatory Atherosclerosis in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Pediatric CKD and Cardivascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Von Willebrand Factor and Thrombosis: Risk Factor, Actor and Pharmacological Target
Current Vascular Pharmacology